Lu Wang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biochemistry top 5%
- Phytochemicals and Antioxidant Activities
Papers in
- Oncology 24
- Cytokine Signaling Pathways and Interactions 8
- Immunology 17
- Immune Cell Function and Interaction 5
- Immune cells in cancer 5
- Co-authors
- Shuwen Yu (11 shared papers)Min Jiang (2 shared papers)Shuangshuang Li (1 shared paper)Qi Long Lu (1 shared paper)Ben Yang Zhao (1 shared paper)Li Sun (1 shared paper)Xianglin Yuan (1 shared paper)Mingsheng Zhang (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (8 papers)Scientific Reports (3 papers)Frontiers in Oncology (3 papers)Chemico-Biological Interactions (2 papers)Angewandte Chemie International Edition (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lu Wang
112 papers receiving 3.9k citations
Lu Wang's Hit Papers
Peers
Comparison fields: 5 of 144
- Cancer Research 564
- Biochemistry 176
- Oncology 707
- Immunology 536
- Molecular Biology 1.3k
Countries citing papers authored by Lu Wang
This map shows the geographic impact of Lu Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Wang more than expected).
Fields of papers citing papers by Lu Wang
This network shows the impact of papers produced by Lu Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Wang. The network helps show where Lu Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 119 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy Hit paper breakdown → | 2024 | 274 |
| 2 | 2016 | 248 | |
| 3 | PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K/AKT signaling in tumor cells and phenotypic polarization of macrophages Hit paper breakdown → | 2022 | 210 |
| 4 | 2012 | 158 | |
| 5 | 2007 | 148 | |
| 6 | 2016 | 148 | |
| 7 | 2020 | 127 | |
| 8 | 2019 | 111 | |
| 9 | 2022 | 103 | |
| 10 | 2020 | 92 | |
| 11 | 2014 | 89 | |
| 12 | 2021 | 82 | |
| 13 | 2006 | 82 | |
| 14 | 2022 | 78 | |
| 15 | 2017 | 76 | |
| 16 | 2007 | 75 | |
| 17 | 2017 | 74 | |
| 18 | 2020 | 72 | |
| 19 | 2015 | 65 | |
| 20 | 2015 | 59 |
About Lu Wang
Lu Wang is a scholar working on Oncology, Immunology, Cancer Research, Molecular Biology and Pharmacology, having authored 119 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (8 papers), Cancer-related molecular mechanisms research (8 papers), Phytochemistry and Biological Activities (7 papers), Immune Cell Function and Interaction (5 papers), Natural product bioactivities and synthesis (5 papers), Immune cells in cancer (5 papers), Circular RNAs in diseases (5 papers) and Cancer, Lipids, and Metabolism (4 papers). The work is most often cited by research in Cancer Research (564 citations), Biochemistry (176 citations), Oncology (707 citations), Immunology (536 citations) and Molecular Biology (1.3k citations). Lu Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shuwen Yu, Min Jiang, Shuangshuang Li, Qi Long Lu, Shuangshuang Li, Ben Yang Zhao, Li Sun, Xianglin Yuan, Mingsheng Zhang and Ping Peng. Their work appears in journals such as Biomedicine & Pharmacotherapy, Scientific Reports, Frontiers in Oncology, Chemico-Biological Interactions and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.